Ameritas Investment Partners’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $614K | Buy |
7,524
+1,085
| +17% | +$78.3K | 0.02% | 818 |
|
|
2026
Q1 | $439K | Hold |
6,439
| – | – | 0.01% | 882 |
|
|
2025
Q4 | $489K | Sell |
6,439
-55
| -0.8% | -$4K | 0.01% | 833 |
|
|
2025
Q3 | $399K | Sell |
6,494
-1,442
| -18% | -$75.1K | 0.01% | 905 |
|
|
2025
Q2 | $388K | Buy |
7,936
+231
| +3% | +$11K | 0.01% | 945 |
|
|
2025
Q1 | $393K | Sell |
7,705
-263
| -3% | -$13.1K | 0.01% | 923 |
|
|
2024
Q4 | $360K | Buy |
7,968
+253
| +3% | +$10.8K | 0.01% | 980 |
|
|
2024
Q3 | $286K | Buy |
7,715
+536
| +7% | +$17.9K | 0.01% | 1108 |
|
|
2024
Q2 | $220K | Sell |
7,179
-280
| -4% | -$9.07K | 0.01% | 1203 |
|
|
2024
Q1 | $217K | Hold |
7,459
| – | – | 0.01% | 1228 |
|
|
2023
Q4 | $206K | Buy |
7,459
+421
| +6% | +$9.63K | 0.01% | 1248 |
|
|
2023
Q3 | $158K | Buy |
7,038
+1,188
| +20% | +$44.2K | 0.01% | 1349 |
|
|
2023
Q2 | $238K | Buy |
5,850
+208
| +4% | +$10.2K | 0.01% | 1032 |
|
|
2023
Q1 | $273K | Buy |
5,642
+196
| +4% | +$8.96K | 0.01% | 941 |
|
|
2022
Q4 | $258K | Hold |
5,446
| – | – | 0.01% | 997 |
|
|
2022
Q3 | $273K | Hold |
5,446
| – | – | 0.01% | 919 |
|
|
2022
Q2 | $218K | Hold |
5,446
| – | – | 0.01% | 1025 |
|
|
2022
Q1 | $203K | Hold |
5,446
| – | – | 0.01% | 1178 |
|
|
2021
Q4 | $217K | Hold |
5,446
| – | – | 0.01% | 1182 |
|
|
2021
Q3 | $203K | Hold |
5,446
| – | – | 0.01% | 1192 |
|
|
2021
Q2 | $230K | Buy |
5,446
+270
| +5% | +$11.6K | 0.01% | 1140 |
|
|
2021
Q1 | $245K | Hold |
5,176
| – | – | 0.01% | 1077 |
|
|
2020
Q4 | $316K | Sell |
5,176
-190
| -4% | -$11.2K | 0.01% | 904 |
|
|
2020
Q3 | $251K | Hold |
5,366
| – | – | 0.01% | 925 |
|
|
2020
Q2 | $272K | Hold |
5,366
| – | – | 0.01% | 890 |
|
|
2020
Q1 | $239K | Buy |
5,366
+174
| +3% | +$8.76K | 0.01% | 853 |
|
|
2019
Q4 | $249K | Buy |
5,192
+309
| +6% | +$13.1K | 0.01% | 964 |
|
|
2019
Q3 | $165K | Hold |
4,883
| – | – | 0.01% | 1165 |
|
|
2019
Q2 | $220K | Buy |
4,883
+641
| +15% | +$25.3K | 0.01% | 1007 |
|
|
2019
Q1 | $160K | Buy |
4,242
+323
| +8% | +$10.8K | 0.01% | 1180 |
|
|
2018
Q4 | $135K | Hold |
3,919
| – | – | 0.01% | 1192 |
|
|
2018
Q3 | $184K | Hold |
3,919
| – | – | 0.01% | 1136 |
|
|
2018
Q2 | $132K | Buy |
3,919
+503
| +15% | +$15.7K | 0.01% | 1345 |
|
|
2018
Q1 | $92K | Hold |
3,416
| – | – | ﹤0.01% | 1536 |
|
|
2017
Q4 | $57K | Buy |
3,416
+804
| +31% | +$13.6K | ﹤0.01% | 1858 |
|
|
2017
Q3 | $54K | Hold |
2,612
| – | – | ﹤0.01% | 1851 |
|
|
2017
Q2 | $48K | Hold |
2,612
| – | – | ﹤0.01% | 1932 |
|
|
2017
Q1 | $26K | Buy |
+2,612
| New | +$31.6K | ﹤0.01% | 2265 |
|
Other funds holding PTCT
Ameritas Investment Partners's PTCT Position: Q2 2026 in Review
Ameritas Investment Partners increased its PTC Therapeutics (PTCT) stake by 17% in Q2 2026, buying an estimated $78.3K and bringing the position to 7,524 shares worth $614K. The position accounts for 0.02% of the portfolio, ranked #818.
Ameritas Investment Partners first reported a position in PTCT in Q1 2017 and has held it in 38 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Ameritas Investment Partners held 7,524 shares of PTC Therapeutics worth $614K as of Q2 2026.
- Ameritas Investment Partners bought 1,085 PTC Therapeutics shares in Q2 2026, an estimated $78.3K.
- PTC Therapeutics made up 0.02% of Ameritas Investment Partners's portfolio in Q2 2026, its #818 holding.
- Ameritas Investment Partners first reported a position in PTC Therapeutics in Q1 2017 and has held it in 38 quarters since.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.